About: ERGIC2 is a research topic. Over the lifetime, 5 publications have been published within this topic receiving 148 citations. The topic is also known as: Erv41 & PTX1.
TL;DR: It is found that endogenous WLS binds Wnts in the endoplasmic reticulum (ER), cycles to the PM, and then returns to the ER through the Golgi, an integral part of the WLS transport cycle.
TL;DR: In this paper, the protein-protein interactions of β-amyloid in normal rabbit brain were examined to identify the biochemical receptors for β-amyloid and found that these receptors are involved in low density lipoprotein and cholesterol transport and metabolism, including sortilin, endoplasmic reticulum-Golgi intermediate compartment 2 (ERGIC2), ERGIC-53, steroid 5α-reductase and apolipoprotein B.
TL;DR: The E3 ubiquitin ligase membrane-associated ring-CH–type finger 2 (MARCH2) is reported to be involved in intracellular vesicular trafficking, and the regulation of the early secretory pathway by MARCH2 and into ERGIC3 function is reported.
TL;DR: The new data on O toferlin’s interactome suggest that Otoferlin can form different, tissue-specific protein complexes.
Abstract: Background: Otoferlin, a postulated calcium sensor of 230 kDa, was proposed to trigger calcium dependent fusion of vesicles with plasma membrane in the ribbon synapses of cochlear IHCs. Otoferlin’s interaction with Rab8b and Myo6, proteins involved in the intracellular membrane trafficking, extended the previous hypothesis assigning Otoferlin an additional role in trans-Golgi trafficking. Here, we present another Otoferlin binding partner, Ergic2, a protein with a still unknown function but presenting sequence homology to other proteins involved in ER/Golgi vesicle trafficking. Methods: Novel binding partners of Otoferlin were searched by yeast two-hybrid screening in a rodent cochlear cDNA library (P3-P15). RT-PCR, western blot, immunohistochemistry staining and co-immunoprecipitation were applied to analyze and confirm an interaction between Ergic2 and Otoferlin. Results: The Y-2-H screening, using baits covering parts of Otoferlin’s C2D domain, identified Ergic2 as an interacting protein for Otoferlin. Both are co-expressed (mRNA and protein level) in rodent cochlea and brain before- and after-onset of hearing. By RT-PCR Ergic2 was detected in cochlear IHCs and OHCs and in brain regions where Otoferlin is known to be present. Co-localization studies revealed an overlap of Ergic2 and Otoferlin signals in IHCs and neurons of cerebral cortical layer I making Ergic2 the promising binding candidate. However, while Ergic2 was co-precipitated by an anti-Otoferlin antibody in protein lysates from murine brain, this specific protein interaction was not detected in cochlea. Conclusion: Our new data on Otoferlin’s interactome suggest that Otoferlin can form different, tissue-specific protein complexes.
TL;DR: A variant ERGIC2 transcript with a four base deletion at the junction of exons 8–9, resulting in frame shift after codon #189 is identified, and a truncated protein of 215 residues is predicted as compared with the 377-residue wild-type (WT) protein.
Abstract: ERGIC2 (formerly known as PTX1) is a gene identified by subtractive hybridization on the basis that it is expressed in normal human prostate, but not in prostate carcinoma. It is unrelated to the gene encoding pituitary homeobox protein (Ptx1 or Pitx1), which regulates pituitary hormone gene expression. Based on sequence homology with the yeast Erv41 protein, it is suggested that the ERGIC2 protein is an endoplasmic reticulum (ER) resident protein involved in protein trafficking between the ER and Golgi intermediate compartment (ERGIC) and cis-Golgi. However, studies from our laboratory and others have shown that it may have other functions. In this study, we have identified a variant ERGIC2 transcript with a four base deletion at the junction of exons 8–9, resulting in frame shift after codon #189. As a result, a truncated protein of 215 residues (24.5 kDa) is predicted as compared with the 377-residue (42.6 kDa) wild-type (WT) protein. The truncated variant ERGIC2 protein loses 45% of the luminal domain...